TONIX Pharmaceuticals, Inc. Elects Charles Mather to Its Board of Directors

NEW YORK--(BUSINESS WIRE)--TONIX Pharmaceuticals, a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, announced the appointment of Charles Mather to the Company’s Board of Directors, increasing the size of the Board to seven members.

Back to news